Table of Contents
Overview
New York, NY – Feb 05, 2026 – The Global Endoscopic Ultrasound Needles Market Size is expected to be worth around USD 267.7 Million by 2033, from USD 158.2 Million in 2023, growing at a CAGR of 5.4% during the forecast period from 2024 to 2033.
Endoscopic ultrasound (EUS) needles are specialized medical devices designed to support accurate tissue acquisition and diagnostic precision during endoscopic ultrasound procedures. These needles play a critical role in minimally invasive diagnosis, particularly in gastroenterology, oncology, and pulmonary medicine.
The basic formation of an endoscopic ultrasound needle consists of three primary components: the needle shaft, the handle assembly, and the stylet. The needle shaft is typically manufactured from high-grade stainless steel or advanced alloys to ensure durability, flexibility, and resistance to bending during complex procedures. It is engineered to pass smoothly through the working channel of an echoendoscope while maintaining optimal ultrasound visibility.
The handle assembly provides ergonomic control for clinicians, enabling precise advancement and retraction of the needle. Integrated locking mechanisms are commonly incorporated to enhance safety and procedural stability. The stylet, positioned within the needle lumen, is designed to prevent tissue contamination during insertion and to facilitate clean sample collection when withdrawn.
Endoscopic ultrasound needles are available in multiple gauges, commonly ranging from 19G to 25G, allowing clinicians to select the appropriate configuration based on target tissue, lesion location, and diagnostic requirements. Advancements in tip design, including cutting and fine-needle biopsy structures, have further improved sample adequacy and diagnostic yield.
Overall, the standardized formation of endoscopic ultrasound needles supports consistent performance, procedural safety, and high diagnostic accuracy, reinforcing their importance in modern minimally invasive diagnostic practices.
Key Takeaways
- In 2023, the Endoscopic Ultrasound Needles market recorded a revenue of USD 158.2 million and is projected to expand at a CAGR of 5.4%, reaching USD 267.7 million by 2033.
- Based on product type, the market is categorized into biopsy needles and aspiration needles, with biopsy needles emerging as the leading segment, accounting for 54.1% of the total market share in 2023.
- By application, the market is segmented into enteral EUS needles and bronchial EUS needles. Among these, bronchial EUS needles dominated the segment, capturing a substantial share of 57.2%.
- In terms of end users, hospitals represented the largest revenue-generating segment, contributing 62.3% of the overall market in 2023.
- Regionally, North America maintained its leading position, holding a market share of 41.1% during the same year.
Regional Analysis
North America Leads the Endoscopic Ultrasound Needles Market
North America accounted for the largest revenue share of 41.1% in the Endoscopic Ultrasound Needles market, supported by a well-established healthcare system and advanced medical infrastructure. The region is characterized by a high prevalence of cancer, which has increased the adoption of advanced diagnostic procedures across oncology, pulmonology, and gastroenterology in both the United States and Canada.
The strong presence of major market players further contributes to regional market dominance. According to data published by the American Cancer Society in 2022, the United States recorded approximately 343,040 new cases of digestive system cancers and about 395,600 new cases of genital system cancers among both males and females. The high incidence of these conditions has reinforced the demand for effective diagnostic and therapeutic solutions, including endoscopic ultrasound-guided procedures.
Asia Pacific Expected to Register the Fastest Growth
The Asia Pacific region is projected to witness the highest compound annual growth rate during the forecast period. Market expansion in the region is being driven by increasing healthcare expenditure, ongoing advancements in cancer treatment, and a rising burden of chronic diseases.
Data from the National Institutes of Health indicate that Asia experiences a notably high incidence and mortality rate of gastric cancer, attributed to factors such as widespread Helicobacter pylori infection, dietary patterns, smoking, and high alcohol consumption. As a result, the growing prevalence of stomach cancer is expected to generate significant growth opportunities for the endoscopic ultrasound needles market across the region.
Emerging Trends
- Shift Toward Fine Needle Biopsy (FNB): The adoption of fine needle biopsy needles is increasing due to their ability to preserve tissue architecture and deliver higher-quality diagnostic samples. Compared with fine needle aspiration, FNB improves histological assessment and overall diagnostic confidence.
- Advancements in Needle Tip Design: Innovative fork-tip and crown-tip needle designs are gaining traction as they enable sufficient tissue acquisition with fewer punctures. This advancement contributes to shorter procedure durations, improved sampling efficiency, and reduced patient discomfort during endoscopic ultrasound procedures.
- Introduction of Rotational Tip Technologies: Needles incorporating rotational tip mechanisms have emerged to enhance tissue penetration while minimizing forward force. These designs support consistent tissue yield and are particularly beneficial when sampling fibrotic or technically challenging lesions.
- Expanded Availability of Needle Gauges: The routine availability of multiple needle gauges, including 19G, 22G, and 25G, allows clinicians to optimize sampling strategies. Gauge selection can be adjusted based on lesion location, tissue density, and required core sample size.
- Rising Demand for High-Quality Cellular Samples: The growth of personalized and precision medicine has increased demand for needles that maximize cell count and preserve microarchitecture. These requirements are essential for molecular profiling, genomic testing, and targeted therapy decision-making.
Key Use Cases
- Diagnosis of Pancreatic Masses: Endoscopic ultrasound-guided fine needle aspiration was performed in 91% of pancreatic lesion cases, with an average of 2.6 needle passes per procedure. This approach consistently delivered sufficient diagnostic material for accurate clinical assessment.
- Detection of Lymph Node Metastasis: Both EUS-guided fine needle biopsy and aspiration techniques have demonstrated high sensitivity in identifying metastatic lymph nodes. Accurate staging was achieved in more than 85% of evaluated cases, supporting informed treatment planning.
- Sampling of Subepithelial Gastrointestinal Tumors: Reliable tissue acquisition from mucosal and submucosal tumors in the stomach and esophagus has been achieved using EUS-guided needles. Diagnostic success rates exceeded 80% across suspected gastrointestinal tumor cases.
- Therapeutic Drainage and Targeted Injection: EUS-guided needle access has been effectively applied in pancreatic pseudocyst drainage and celiac plexus neurolysis. These interventions resulted in pain score reductions of up to 60% among selected patient populations.
- Reduction in Additional Diagnostic Procedures: In approximately 88% of procedures, EUS-guided interventions achieved diagnostic or therapeutic objectives. This outcome significantly reduced the need for follow-up imaging studies or invasive surgical sampling.
Frequently Asked Questions on Endoscopic Ultrasound Needles
- What types of endoscopic ultrasound needles are commonly available?
Endoscopic ultrasound needles are mainly classified into fine needle aspiration (FNA) and fine needle biopsy (FNB) needles. FNA needles collect cytology samples, while FNB needles are designed to retrieve core tissue samples for histological analysis. - How do endoscopic ultrasound needles improve diagnostic accuracy?
Diagnostic accuracy is improved through real-time ultrasound guidance, enabling precise targeting of lesions. This approach reduces sampling errors, increases tissue adequacy, and enhances the detection of malignancies compared to conventional biopsy or imaging-based diagnostic techniques. - What materials are used in endoscopic ultrasound needles?
Endoscopic ultrasound needles are typically manufactured using stainless steel or nitinol alloys. These materials provide flexibility, durability, and resistance to bending, ensuring smooth navigation through endoscopes while maintaining sharpness for effective tissue penetration. - Are endoscopic ultrasound needles safe for patients?
Endoscopic ultrasound needles are considered safe when used by trained clinicians. The procedure is minimally invasive and associated with low complication rates, such as minor bleeding or infection, making it suitable for repeated diagnostic and staging applications. - What factors are driving the growth of the endoscopic ultrasound needles market?
Market growth is driven by rising prevalence of gastrointestinal cancers, increasing adoption of minimally invasive diagnostic procedures, and growing demand for early and accurate cancer detection. Technological advancements in needle design further support market expansion. - How is technological innovation influencing the market?
Technological innovation has led to the development of advanced FNB needles with improved tissue acquisition and sample quality. Enhanced tip geometry and flexible designs have increased procedural efficiency, supporting broader clinical adoption across hospitals and specialty clinics. - How does regional demand vary in the global market?
North America dominates the market due to advanced healthcare infrastructure and high screening rates. Asia-Pacific is expected to witness the fastest growth, driven by expanding healthcare access, increasing cancer incidence, and rising investment in endoscopy technologies.
Conclusion
The endoscopic ultrasound needles market represents a critical component of modern minimally invasive diagnostics, supported by advancements in needle design, expanding clinical applications, and growing adoption of precision medicine. Strong market growth is underpinned by rising cancer prevalence, increasing use of EUS-guided procedures, and the shift toward fine needle biopsy for higher diagnostic accuracy.
North America continues to lead due to advanced healthcare infrastructure, while Asia Pacific offers significant growth potential driven by unmet diagnostic needs and increasing healthcare investment. Continuous technological innovation is expected to further enhance clinical outcomes and sustain long-term market expansion.
